BDBM430726 (3,4-dichlorophenyl)(3-(2-(4-fluorophenyl)thiazol-4-yl)-8-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone::US10544150, Compound 109

SMILES CC1N(CCn2c1nnc2-c1csc(n1)-c1ccc(F)cc1)C(=O)c1ccc(Cl)c(Cl)c1

InChI Key InChIKey=APLAMVLDOSZMHN-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 430726   

TargetNeuromedin-K receptor(Human)
Ogeda

US Patent
LigandPNGBDBM430726(US10544150, Compound 109 | (3,4-dichlorophenyl)(3-...)
Affinity DataKi: <500nMAssay Description:The ability of the compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist SB222200 was assessed by an in vitro r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent